Bivalacqua T J, Dalal A, Champion H C, Kadowitz P J
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Am J Physiol. 1999 Nov;277(5):E838-47. doi: 10.1152/ajpendo.1999.277.5.E838.
Hemodynamic responses to angiotensin II and the role of AT(1) and AT(2) receptors and the autonomic nervous system in mediating acute responses to angiotensin II were investigated in anesthetized CD1 mice. Injections of angiotensin II caused dose-related increases in systemic arterial pressure that were antagonized by candesartan. Pressor responses to angiotensin II were not altered by PD-123,319 in doses up to 25 mg/kg iv. At the lowest dose studied (20 microgram/kg iv), the inhibitory effects of candesartan were competitive, whereas at the highest dose (100 microgram/kg iv) the dose-response curve for angiotensin II was shifted to the right in a nonparallel manner with inhibitory effects that could not be surmounted. The inhibitory effects of candesartan were selective and were similar in animals pretreated with enalaprilat (1 mg/kg iv) to reduce endogenous angiotensin II production. Acute pressor responses to angiotensin II were not altered by propranolol (200 microgram/kg iv), phentolamine (200 microgram/kg iv), or atropine (1 mg/kg iv) but were enhanced by hexamethonium (5 mg/kg iv). Increases in total peripheral resistance induced by angiotensin II were inhibited by the AT(1)-receptor antagonist but were not altered by AT(2)-, alpha-, or beta-receptor antagonists. These results suggest that acute pressor responses to angiotensin II are mediated by AT(1) receptors, are buffered by the baroreceptors, and are not modulated by effects on AT(2) receptors and that activation of the sympathetic nervous system plays little if any role in mediating rapid hemodynamic responses to the peptide in anesthetized CD1 mice.
在麻醉的CD1小鼠中,研究了对血管紧张素II的血流动力学反应以及AT(1)和AT(2)受体及自主神经系统在介导对血管紧张素II的急性反应中的作用。注射血管紧张素II导致全身动脉压呈剂量相关增加,坎地沙坦可拮抗此作用。静脉注射剂量高达25mg/kg的PD - 123,319对血管紧张素II的升压反应无改变。在研究的最低剂量(静脉注射20微克/千克)时,坎地沙坦的抑制作用是竞争性的,而在最高剂量(静脉注射100微克/千克)时,血管紧张素II的剂量反应曲线以非平行方式向右移动,抑制作用无法克服。坎地沙坦的抑制作用具有选择性,在用依那普利拉(静脉注射1mg/kg)预处理以减少内源性血管紧张素II产生的动物中效果相似。普萘洛尔(静脉注射200微克/千克)、酚妥拉明(静脉注射200微克/千克)或阿托品(静脉注射1mg/kg)对血管紧张素II的急性升压反应无改变,但六甲铵(静脉注射5mg/kg)可增强该反应。血管紧张素II诱导的总外周阻力增加被AT(1)受体拮抗剂抑制,但不受AT(2)、α或β受体拮抗剂影响。这些结果表明,对血管紧张素II的急性升压反应由AT(1)受体介导,受压力感受器缓冲,不受对AT(2)受体的影响调节,并且交感神经系统的激活在介导麻醉的CD1小鼠对该肽的快速血流动力学反应中作用甚微(如果有作用的话)。